Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Plowchalk, D. R.
Right arrow Articles by Teeguarden, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Plowchalk, D. R.
Right arrow Articles by Teeguarden, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Toxicological Sciences 69, 60-78 (2002)
Copyright © 2002 by the Society of Toxicology

ENDOCRINE TOXICOLOGY

Development of a Physiologically Based Pharmacokinetic Model for Estradiol in Rats and Humans: A Biologically Motivated Quantitative Framework for Evaluating Responses to Estradiol and Other Endocrine-Active Compounds

David R. Plowchalk*,1 and Justin Teeguarden{dagger}

* DuPont Haskell Laboratory for Health and Biomedical Sciences, Newark, Delaware 19714; and {dagger} The K.S. Crump Group, Inc., ICF Consulting, Research Triangle Park, North Carolina 27709

A physiologically based pharmacokinetic (PBPK) model for estradiol (E2) in rats and humans (male and female) was developed to provide a quantitative tool for evaluating the importance of physiological parameters on E2 blood and tissue concentration time-course and for predicting blood and tissue concentrations in rats and humans. A hepatic extraction model was developed to evaluate the significance of plasma protein binding on the hepatic extraction of E2 and the approach was integrated into the E2 model. Sufficient data was available to parameterize and validate oral and iv routes. The E2 model simulations of E2 blood and tissue concentrations compared well to experimental values. Estrogen receptor content strongly impacts distribution and elimination kinetics of E2 as well as tissue concentrations. The prolonged terminal elimination phase seen after iv bolus administration reflects the slow release of receptor bound E2 from tissues. E2 uptake behavior in the ovariectomized, but not intact rat uterus, was best described as diffusion-limited. Simulations with the hepatic extraction model predicted extensive binding of E2 to albumin (rat) and SHBG (sex-hormone binding globulin humans), although hepatic extraction does not appear to be restricted to the unbound fraction, implying that the total plasma E2 concentration is important when considering hepatic uptake. Important determinants of E2 disposition are tissue ER content and binding affinity, nonreceptor binding proteins, vascular permeability, partition coefficients, hepatic blood flow, and extrahepatic metabolism. As an integral part of a research program, the quantitative framework developed for E2 can be extended to other endocrine-active compounds (EACs) and used to evaluate the biological activity of EACs.

Key Words: PBPK model; endocrine system; estradiol; risk assessment; endocrine-active compound (EAC).


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Toxicol SciHome page
K. H. Watanabe, Z. Li, K. J. Kroll, D. L. Villeneuve, N. Garcia-Reyero, E. F. Orlando, M. S. Sepulveda, T. W. Collette, D. R. Ekman, G. T. Ankley, et al.
A Computational Model of the Hypothalamic-Pituitary-Gonadal Axis in Male Fathead Minnows Exposed to 17{alpha}-Ethinylestradiol and 17{beta}-Estradiol
Toxicol. Sci., June 1, 2009; 109(2): 180 - 192.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
M. L. Gargas, L. M. Sweeney, M. W. Himmelstein, L. H. Pottenger, J. S. Bus, and J. W. Holder
Physiologically based Pharmacokinetic Modeling of Chloroethane Disposition in Mice, Rats, and Women
Toxicol. Sci., July 1, 2008; 104(1): 54 - 66.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
R. J. Kavlock, G. Ankley, J. Blancato, M. Breen, R. Conolly, D. Dix, K. Houck, E. Hubal, R. Judson, J. Rabinowitz, et al.
Computational Toxicology--A State of the Science Mini Review
Toxicol. Sci., May 1, 2008; 103(1): 14 - 27.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
J. G. Teeguarden, J. M. Waechter Jr., H. J. Clewell III, T. R. Covington, and H. A. Barton
Evaluation of Oral and Intravenous Route Pharmacokinetics, Plasma Protein Binding, and Uterine Tissue Dose Metrics of Bisphenol A: A Physiologically Based Pharmacokinetic Approach
Toxicol. Sci., June 1, 2005; 85(2): 823 - 838.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.